PURE
PURE Bioscience, Inc.
Price Chart
Latest Quote
$0.07
+0.00 (+0.00%)
Current Price
| Previous Close | $0.07 |
| Open | $0.06 |
| Day High | $0.08 |
| Day Low | $0.06 |
| Volume | 3,000 |
Stock Information
| Shares Outstanding | 130.02M |
| Total Debt | $6.14M |
| Cash Equivalents | $198K |
| Revenue | $2.41M |
| Net Income | $-2.16M |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Market Cap | $9.10M |
| EPS (TTM) | $-0.02 |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $12.83M |
| Sales | $2.41M |
| Income | $-2.16M |
| Book/sh | $-0.06 |
| Cash/sh | $0.00 |
| Employees | 11 |
Financial Ratios
| Quick Ratio | 0.15 |
| Current Ratio | 0.26 |
Returns & Margins
| ROA | -181.90% |
| Gross Margin | 59.78% |
| Operating Margin | -153.83% |
| Profit Margin | -89.78% |
Ownership
| Insider Ownership | 35.50% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| PEG | 1.03 |
| P/S | 3.78 |
| P/B | -1.25 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.07 |
| SMA50 | $0.07 |
| SMA200 | $0.07 |
| RSI | 40.00 |
| ATR | 0.0093 |
| Shares Float | 72.16M |
| Short Float | 1.86% |
| Short Ratio | 2.56 |
| Volatility | 0.16 |
| Rel Volume | 0.33 |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| Quarter | -12.50% |
| 6 Months | +40.00% |
| YTD | +75.00% |
| Year | -22.22% |
| 3 Years | -50.00% |
| 5 Years | -86.00% |
| 10 Years | -93.33% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.07 | 10,100 |
| 2026-06-17 | $0.07 | 10,600 |
| 2026-06-16 | $0.06 | 2,000 |
| 2026-06-15 | $0.07 | 1,400 |
| 2026-06-12 | $0.07 | 22,900 |
| 2026-06-11 | $0.07 | 500 |
| 2026-06-10 | $0.07 | 28,500 |
| 2026-06-09 | $0.07 | 600 |
| 2026-06-08 | $0.07 | 4,600 |
| 2026-06-05 | $0.07 | 20,800 |
| 2026-06-04 | $0.07 | 8,800 |
| 2026-06-03 | $0.06 | 83,300 |
| 2026-06-02 | $0.07 | 24,500 |
| 2026-06-01 | $0.07 | 44,400 |
| 2026-05-29 | $0.08 | 1,600 |
| 2026-05-28 | $0.08 | 98,000 |
| 2026-05-27 | $0.09 | 187,200 |
| 2026-05-26 | $0.07 | 20,800 |
| 2026-05-22 | $0.07 | 35,700 |
| 2026-05-21 | $0.07 | 13,600 |
| 2026-05-20 | $0.07 | 5,700 |
| 2026-05-19 | $0.07 | 22,500 |
About PURE Bioscience, Inc.
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company's technology platform contains silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a ready-to-use hard surface disinfectant and food contact surface sanitizer and disinfectant; PURE Control, eliminates pathogens in produce, such as salmonella, e. coli, and listeria; PURE Multi-Purpose Hi-Foam Floor Cleaner Concentrate, a cleaning product for stainless steel, floors, walls, and painted areas; PURE Multi-Purpose Floor Cleaner, for sanitation in food processing plants, commercial kitchens, healthcare facilities, schools, and hospitality settings; and SILVERION, a SDC-based antimicrobial formulation for use as a raw material ingredient in the manufacturing of personal care products. The company serves food processing, food service and hospitality, healthcare, facility care, transportation, and personal care industries. It sells its products through end-use customers and third-party distributors. The company was incorporated in 1992 and is based in El Cajon, California.
đ° Latest News
No news articles available at the moment. Check back later for updates on PURE.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $811,000 | $906,000 | $853,000 | $1,852,000 |
| Cost Of Revenue | $811,000 | $906,000 | $853,000 | $1,852,000 |
| Total Revenue | $1,963,000 | $1,877,000 | $1,853,000 | $3,927,000 |
| Operating Revenue | $1,955,000 | $1,871,000 | $1,813,000 | $3,698,000 |
| Expenses | ||||
| Interest Expense | $155,000 | $14,000 | $6,000 | $4,000 |
| Total Expenses | $5,094,000 | $5,505,000 | $5,223,000 | $6,238,000 |
| Other Income Expense | $-64,000 | $-319,000 | $-115,000 | $-4,000 |
| Other Non Operating Income Expenses | $-4,000 | $-4,000 | - | $-4,000 |
| Net Non Operating Interest Income Expense | $-155,000 | $-14,000 | $-6,000 | $-4,000 |
| Interest Expense Non Operating | $155,000 | $14,000 | $6,000 | $4,000 |
| Operating Expense | $4,283,000 | $4,599,000 | $4,370,000 | $4,386,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-3,350,000 | $-3,961,000 | $-3,491,000 | $-2,319,000 |
| Net Interest Income | $-155,000 | $-14,000 | $-6,000 | $-4,000 |
| Normalized Income | $-3,290,000 | $-3,646,000 | $-3,376,000 | $-2,319,000 |
| Net Income From Continuing And Discontinued Operation | $-3,350,000 | $-3,961,000 | $-3,491,000 | $-2,319,000 |
| Total Operating Income As Reported | $-3,191,000 | $-3,943,000 | $-3,724,000 | $-2,311,000 |
| Net Income Common Stockholders | $-3,350,000 | $-3,961,000 | $-3,491,000 | $-2,319,000 |
| Net Income | $-3,350,000 | $-3,961,000 | $-3,491,000 | $-2,319,000 |
| Net Income Including Noncontrolling Interests | $-3,350,000 | $-3,961,000 | $-3,491,000 | $-2,319,000 |
| Net Income Continuous Operations | $-3,350,000 | $-3,961,000 | $-3,491,000 | $-2,319,000 |
| Pretax Income | $-3,350,000 | $-3,961,000 | $-3,491,000 | $-2,319,000 |
| Special Income Charges | $-60,000 | $-315,000 | $-115,000 | $0 |
| Operating Income | $-3,131,000 | $-3,628,000 | $-3,370,000 | $-2,311,000 |
| Gross Profit | $1,152,000 | $971,000 | $1,000,000 | $2,075,000 |
| Per Share | ||||
| Diluted EPS | $-0.03 | $-0.04 | $-0.04 | $-0.03 |
| Basic EPS | $-0.03 | $-0.04 | $-0.04 | $-0.03 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-2,987,000 | $-3,515,000 | $-3,157,000 | $-2,143,000 |
| Total Unusual Items | $-60,000 | $-315,000 | $-115,000 | $0 |
| Total Unusual Items Excluding Goodwill | $-60,000 | $-315,000 | $-115,000 | $0 |
| Reconciled Depreciation | $148,000 | $117,000 | $213,000 | $172,000 |
| EBITDA (Bullshit earnings) | $-3,047,000 | $-3,830,000 | $-3,272,000 | $-2,143,000 |
| EBIT | $-3,195,000 | $-3,947,000 | $-3,485,000 | $-2,315,000 |
| Diluted Average Shares | $111,856,473 | $111,404,418 | $88,835,424 | $87,174,312 |
| Basic Average Shares | $111,856,473 | $111,404,418 | $88,835,424 | $87,174,312 |
| Diluted NI Availto Com Stockholders | $-3,350,000 | $-3,961,000 | $-3,491,000 | $-2,319,000 |
| Impairment Of Capital Assets | $60,000 | $315,000 | $354,000 | $0 |
| Research And Development | $302,000 | $297,000 | $319,000 | $339,000 |
| Selling General And Administration | $3,981,000 | $4,302,000 | $4,051,000 | $4,047,000 |
| Other Special Charges | - | - | $-239,000 | - |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-2,864,000 | $272,000 | $3,909,000 | $2,967,000 |
| Total Assets | $818,000 | $1,825,000 | $4,484,000 | $4,303,000 |
| Total Non Current Assets | $13,000 | $221,000 | $620,000 | $1,106,000 |
| Current Assets | $805,000 | $1,604,000 | $3,864,000 | $3,197,000 |
| Restricted Cash | $75,000 | $75,000 | $75,000 | $75,000 |
| Prepaid Assets | $27,000 | $61,000 | $18,000 | $32,000 |
| Inventory | $56,000 | $88,000 | $179,000 | $332,000 |
| Receivables | $298,000 | $285,000 | $201,000 | $368,000 |
| Accounts Receivable | $298,000 | $285,000 | $201,000 | $368,000 |
| Cash Cash Equivalents And Short Term Investments | $349,000 | $1,095,000 | $3,391,000 | $2,390,000 |
| Cash And Cash Equivalents | $349,000 | $1,095,000 | $3,391,000 | $2,390,000 |
| Cash Financial | $349,000 | $1,095,000 | $3,391,000 | - |
| Goodwill And Other Intangible Assets | - | - | $0 | $366,000 |
| Other Intangible Assets | - | - | - | $366,000 |
| Debt | ||||
| Net Debt | $2,600,000 | - | - | - |
| Total Debt | $2,949,000 | $1,021,000 | - | $239,000 |
| Long Term Debt And Capital Lease Obligation | $2,949,000 | $1,021,000 | - | - |
| Long Term Debt | $2,949,000 | $1,021,000 | - | - |
| Current Debt And Capital Lease Obligation | - | - | - | $239,000 |
| Current Debt | - | - | - | $239,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,682,000 | $1,553,000 | $575,000 | $970,000 |
| Total Non Current Liabilities Net Minority Interest | $2,949,000 | $1,021,000 | $0 | $0 |
| Current Liabilities | $733,000 | $532,000 | $575,000 | $970,000 |
| Payables And Accrued Expenses | $733,000 | $532,000 | $575,000 | $731,000 |
| Payables | $601,000 | $422,000 | $488,000 | $593,000 |
| Accounts Payable | $601,000 | $422,000 | $488,000 | $593,000 |
| Equity | ||||
| Common Stock Equity | $-2,864,000 | $272,000 | $3,909,000 | $3,333,000 |
| Total Equity Gross Minority Interest | $-2,864,000 | $272,000 | $3,909,000 | $3,333,000 |
| Stockholders Equity | $-2,864,000 | $272,000 | $3,909,000 | $3,333,000 |
| Retained Earnings | $-136,595,000 | $-133,245,000 | $-129,284,000 | $-125,793,000 |
| Other | ||||
| Ordinary Shares Number | $111,856,473 | $111,856,473 | $111,356,473 | $87,223,141 |
| Share Issued | $111,856,473 | $111,856,473 | $111,356,473 | $87,223,141 |
| Tangible Book Value | $-2,864,000 | $272,000 | $3,909,000 | $2,967,000 |
| Invested Capital | $85,000 | $1,293,000 | $3,909,000 | $3,572,000 |
| Working Capital | $72,000 | $1,072,000 | $3,289,000 | $2,227,000 |
| Total Capitalization | $85,000 | $1,293,000 | $3,909,000 | $3,333,000 |
| Additional Paid In Capital | $132,612,000 | $132,398,000 | $132,079,000 | $128,253,000 |
| Capital Stock | $1,119,000 | $1,119,000 | $1,114,000 | $873,000 |
| Common Stock | $1,119,000 | $1,119,000 | $1,114,000 | $873,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Current Accrued Expenses | $132,000 | $110,000 | $87,000 | $138,000 |
| Net PPE | $13,000 | $221,000 | $620,000 | $740,000 |
| Accumulated Depreciation | $-1,602,000 | $-1,394,000 | $-1,040,000 | $-839,000 |
| Gross PPE | $1,615,000 | $1,615,000 | $1,660,000 | $1,579,000 |
| Machinery Furniture Equipment | $1,615,000 | $1,615,000 | $1,582,000 | $1,516,000 |
| Finished Goods | $52,000 | $77,000 | $160,000 | $315,000 |
| Raw Materials | $4,000 | $11,000 | $19,000 | $17,000 |
| Construction In Progress | - | $0 | $78,000 | $63,000 |
| Line Of Credit | - | - | $0 | $239,000 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-2,531,000 | $-3,311,000 | $-2,499,000 | $-1,688,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-2,531,000 | $-3,278,000 | $-2,418,000 | $-1,167,000 |
| Cash Flow From Continuing Operating Activities | $-2,531,000 | $-3,278,000 | $-2,418,000 | $-1,167,000 |
| Operating Gains Losses | - | - | $-239,000 | - |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $-33,000 | $-81,000 | $-521,000 |
| Cash Flow From Continuing Investing Activities | $0 | $-33,000 | $-81,000 | $-521,000 |
| Capital Expenditure | - | $-33,000 | $-81,000 | $-521,000 |
| Financing Activities | ||||
| Financing Cash Flow | $1,785,000 | $1,015,000 | $3,500,000 | $239,000 |
| Cash Flow From Continuing Financing Activities | $1,785,000 | $1,015,000 | $3,500,000 | $239,000 |
| Issuance Of Capital Stock | - | $0 | $3,500,000 | $0 |
| Net Common Stock Issuance | - | $0 | $3,500,000 | $0 |
| Common Stock Issuance | - | $0 | $3,500,000 | $0 |
| Other | ||||
| Issuance Of Debt | $1,785,000 | $1,015,000 | $0 | $239,000 |
| Income Tax Paid Supplemental Data | $5,000 | $5,000 | $2,000 | $4,000 |
| End Cash Position | $424,000 | $1,170,000 | $3,466,000 | $2,465,000 |
| Beginning Cash Position | $1,170,000 | $3,466,000 | $2,465,000 | $3,914,000 |
| Changes In Cash | $-746,000 | $-2,296,000 | $1,001,000 | $-1,449,000 |
| Net Issuance Payments Of Debt | $1,785,000 | $1,015,000 | $0 | $239,000 |
| Net Long Term Debt Issuance | $1,785,000 | $1,015,000 | $0 | $239,000 |
| Long Term Debt Issuance | $1,785,000 | $1,015,000 | $0 | $239,000 |
| Net PPE Purchase And Sale | $0 | $-33,000 | $-81,000 | $-521,000 |
| Purchase Of PPE | $0 | $-33,000 | $-81,000 | $-521,000 |
| Change In Working Capital | $397,000 | $-107,000 | $103,000 | $-11,000 |
| Change In Payables And Accrued Expense | $344,000 | $-37,000 | $-156,000 | $-781,000 |
| Change In Accrued Expense | $143,000 | $6,000 | $0 | - |
| Change In Interest Payable | $143,000 | $6,000 | $0 | - |
| Change In Payable | $201,000 | $-43,000 | $-156,000 | - |
| Change In Account Payable | $201,000 | $-43,000 | $-156,000 | - |
| Change In Prepaid Assets | $34,000 | $-43,000 | $14,000 | $-16,000 |
| Change In Inventory | $32,000 | $57,000 | $78,000 | $65,000 |
| Change In Receivables | $-13,000 | $-84,000 | $167,000 | $721,000 |
| Changes In Account Receivables | $-13,000 | $-84,000 | $167,000 | $721,000 |
| Stock Based Compensation | $214,000 | $324,000 | $567,000 | $841,000 |
| Provisionand Write Offof Assets | $0 | $34,000 | $75,000 | $150,000 |
| Asset Impairment Charge | $60,000 | $315,000 | $354,000 | $0 |
| Depreciation Amortization Depletion | $148,000 | $117,000 | $213,000 | $172,000 |
| Depreciation And Amortization | $148,000 | $117,000 | $213,000 | $172,000 |
| Net Income From Continuing Operations | $-3,350,000 | $-3,961,000 | $-3,491,000 | $-2,319,000 |
| Net Short Term Debt Issuance | - | - | $0 | $239,000 |
| Short Term Debt Issuance | - | - | $0 | $239,000 |
Fetched: 2026-02-02